Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3686166 | 0.86 | TSHR (0.39) | TSHRTDP1ALDH1A1LMNA | |
| SCHEMBL3684334 | 0.86 | TSHR (0.39) | TSHRTDP1ALDH1A1LMNA | |
| SCHEMBL10066792 | 0.83 | TDP1 (0.45) | TSHRTDP1ALDH1A1LMNA | |
| SCHEMBL6025402 | 0.79 | — | — | |
| SCHEMBL2350785 | 0.77 | — | — | |
| SCHEMBL12315009 | 0.77 | — | — | |
| SCHEMBL13627864 | 0.77 | — | — | |
| SCHEMBL4730355 | 0.77 | — | — | |
| SCHEMBL10798332 | 0.74 | TDP1 (0.43) | TSHRTDP1 | |
| SCHEMBL29098228 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119318667-A | Preparation and application of amphiphilic polymer prodrug loaded with nonsteroidal anti-inflammatory drug and platinum drug | 中国石油化工股份有限公司 | 2025-01-17 | — | — | CN | claimed |
| CN-116333285-A | Low-reactivity polyester polyol and preparation method and application thereof | 万华化学集团股份有限公司 | 2023-06-27 | — | — | CN | claimed |
| US-5709737-A | AQUEOUS LIQUID VEHICLE, COLORANT, ALCOHOL ADDITIVE; SUITABLE FOR MICROWAVE DRYING PROCESSES | XEROX CORPORATION (US) | 1998-01-20 | — | — | US | claimed |
| CN-119318667-A | Preparation and application of amphiphilic polymer prodrug loaded with nonsteroidal anti-inflammatory drug and platinum drug | 中国石油化工股份有限公司 | 2025-01-17 | — | — | CN | disclosed |
| CN-116333285-A | Low-reactivity polyester polyol and preparation method and application thereof | 万华化学集团股份有限公司 | 2023-06-27 | — | — | CN | disclosed |
| US-11246877-B2 | Nanoparticles for chemotherapy, targeted therapy, photodynamic therapy, immunotherapy, and any combination thereof | THE UNIVERSITY OF CHICAGO (US) | 2022-02-15 | — | — | US | disclosed |
| US-20190269706-A1 | NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY, PHOTODYNAMIC THERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF | THE UNIVERSITY OF CHICAGO | 2019-09-05 | — | — | US | disclosed |
| EP-3439666-A1 | NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY, PHOTODYNAMIC THERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF | The University of Chicago (US) | 2019-02-13 | — | — | EP | disclosed |
| WO-2017201528-A1 | NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY, PHOTODYNAMIC THERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF | THE UNIVERSITY OF CHICAGO (US) | 2017-11-23 | — | — | WO | disclosed |
| EP-3211017-A1 | POLYURETHANE | Compagnie Générale des Etablissements Michelin (FR) | 2017-08-30 | — | — | EP | disclosed |
| EP-2115033-B1 | POLYURETHANE | MICHELIN & CIE (FR) | 2017-05-17 | — | — | EP | disclosed |
| US-4666618-A | ANTIWEAR AND EXTREME PRESSURE ADDITIVES IN LUBRICANTS OR HYDRAULIC FLUIDS | BAYER AKTIENGESELLSCHAFT (DE) | 1987-05-19 | — | — | US | disclosed |
| EP-0205846-A1 | Process for the preparation of low molecular weight hydroxy-functional (meth)acrylpolymers, their use in the preparation of prepolymers with isocyanate end groups and elastic sealants and adhesives prepared from these polymers | Teroson GmbH (DE) | 1986-12-30 | — | — | EP | disclosed |
| US-4589993-A | Power transmission shift fluids containing two-component friction modifier additive | EXXON RESEARCH & ENGINEERING CO. (US) | 1986-05-20 | — | — | US | disclosed |
| EP-0113199-A2 | Power transmission shift fluids containing two-component friction modifier additive | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1984-07-11 | — | — | EP | disclosed |
| US-4382002-A | Drilling fluids containing an additive composition | EXXON RESEARCH & ENGINEERING CO. (US) | 1983-05-03 | — | — | US | disclosed |
| EP-0068601-A1 | Drilling fluids containing an additive composition | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1983-01-05 | — | — | EP | disclosed |
| US-4344853-A | AUTOMATIC TRANSMISSION FLUIDS | EXXON RESEARCH & ENGINEERING CO. (US) | 1982-08-17 | — | — | US | disclosed |
| US-4322214-A | USING A SULFUR OR SULFURIZED VAT DYE IN AN ALKALINE BATH CONTAINING A MERCAPTO COMPOUND AND A SULFITE SALT; LEVELING | ASAHI CHEMICAL COMPANY LIMITED (JP) | 1982-03-30 | — | — | US | disclosed |
| US-3952063-A | Process for the preparation of an organomercaptophenol from sulfur, a phenol, and an activated olefin or an epoxy compound | GENERAL ELECTRIC COMPANY (US) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190269706-A1 | NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY, PHOTODYNAMIC THERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF | CD274, PDCD1, PDCD1LG2 | TSHR 3605/4885TDP1 3263/4885ALDH1A1 460/4885 |
| US-11246877-B2 | Nanoparticles for chemotherapy, targeted therapy, photodynamic therapy, immunotherapy, and any combination thereof | CD274, PDCD1, PDCD1LG2 | TSHR 3605/4885TDP1 3263/4885ALDH1A1 460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.